Treatment choice in metaplastic breast cancer: A report of 5 cases.

Autor:	Acar T; Department of General Surgery, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Acar N; Department of General Surgery, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Sezgin G; Department of Interventional Radiology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Gokova MB; Department of General Surgery, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Kucukzeybek BB; Department of Pathology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey., Haciyanli M; Department of General Surgery, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
Jazyk:	angličtina
Zdroj:	Northern clinics of Istanbul [North Clin Istanb] 2018 Aug 08; Vol. 5 (4), pp. 365-369. Date of Electronic Publication: 2018 Aug 08 (Print Publication: 2018).
DOI:	10.14744/nci.2018.09124
Abstrakt:	Metaplastic breast carcinoma (MBC) is a general term defining a heterogeneous group that includes biphasic lesions, with both malignant epithelial and mesenchymal tissue components. Although its clinical findings are similar to those present in invasive ductal carcinoma, it rarely presents with the findings of inflammatory breast cancer. It is generally seen in the fifth decade. MBC spreads via lymph and blood circulation. Most common distant metastasis areas include lungs and the bone. Although the treatment generally relies on the same principles applied in invasive ductal carcinoma, a more aggressive treatment should be employed in at-risk groups due to higher rates of local recurrence. In this study, we aimed to discuss clinicopathological features and treatment approach in 5 women with MBC. Competing Interests: Conflict of Interest: No conflict of interest was declared by the authors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu